Healthcare Industry News: Alphatec Spine
News Release - October 31, 2008
Alphatec Spine Expands European Presence; Names Peter Kohlbecher as Vice President, General Manager - EuropeCompany Continues to Develop and Build Global Distribution Network
CARLSBAD, Calif., Oct. 31, 2008 -- (Healthcare Sales & Marketing Network) -- Alphatec Holdings, Inc. (NasdaqGM:ATEC ), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced the addition of Peter Kohlbecher as Vice President, General Manager - Europe.
Mr. Kohlbecher, who will be based in Germany, fills this newly created position to oversee all of Alphatec Spine's European operations. He will be responsible for directing and overseeing Alphatec Spine's marketing and sales expansion in Europe, including efforts to secure experienced spine product distributors that will exclusively sell the Company's products, as well as building relationships with key medical opinion leaders in Europe and helping to manage post-market clinical studies in Europe. In addition, Mr. Kohlbecher will assist in business development activities related to identifying potential in-licensing activities that will augment the Company's spinal product portfolio.
Most recently Mr. Kohlbecher served as the Director of Group Product Management at Aesculap AG, where he successfully directed the turnaround of a medical device business unit with declining revenues into a successful business unit that had double digit revenue growth. Mr. Kohlbecher has worked at Aesculap for over 20 years, and has had increasing roles of business development and sales responsibility.
``We are pleased that we were able to successfully attract someone with the caliber of Peter's international business experience to lead our European business,'' said Dirk Kuyper, Alphatec Spine's President and Chief Executive Officer. ``Given his international medical device marketing and sales experience, we believe he will provide a significant boost to execute our European business development. With the recent CE Mark approval of the OsseoFix system, and the ongoing expansion of our core product line, we expect to see exciting opportunities to grow our presence in the European market.''
In addition, the Company announced that it continues to expand its European presence with the addition of a new exclusive distribution partner, and that product sales with its current European distribution partner continue to grow. During the most recent North American Spine Society (NASS) meeting held in Toronto Canada, the Company conducted training seminars for European surgeons in support of the launch of the OsseoFix Fracture Reduction System and the OsseoFix+ System in Europe.
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings, Inc. (NasdaqGM:ATEC ). Alphatec Spine is a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine. The Company's mission is to combine world-class customer service with innovative, surgeon-driven design that will help improve the aging patient's quality of life. The Company is poised to achieve its goal through new solutions for patients with osteoporosis and other aging spine deformities, improved minimally invasive products and techniques and integrated biologics solutions. In addition to its U.S. operations, the Company also markets its spine products in Europe. In Asia, the Company markets a broad line of spine and orthopedic products through its subsidiary, Alphatec Pacific, Inc. For more information, please visit http://www.alphatecspine.com.
Also visit the Aging Spine Center, http://www.agingspinecenter.com, a web-based information portal for healthcare providers and patients regarding aging spine disorders and their treatment. Alphatec Spine is working with the National Osteoporosis Foundation as well as other clinical portals that provide peer-reviewed content, to populate the Aging Spine Center. The interactive website will enable patients to review pertinent information about all the key disorders that affect the aging spine in an easy-to-understand format that includes videos, graphics and questions that should be asked of caregivers. Medical information will include published abstracts regarding the aging spine.
Forward Looking Statements
This press release may contain ``forward-looking statements'' within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These forward-looking statements include, but are not limited to: Alphatec Spine's ability to accelerate new product momentum, bring to market differentiated products and commercialize its product pipeline. Alphatec Spine cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including, but not limited to, the following: Alphatec Spine's ability to meet its revenue projections, the growth rate of the spine market related to aging and elderly patients, uncertainty of success in developing new products or products currently in Alphatec Spine's pipeline, including the successful launch in both the U.S. and Europe of the OsseoFix and OsseoFix+ systems, and those products that are intended to treat disorders prevalent in aging patients, failure to achieve acceptance of Alphatec Spine's products, including the OsseoFix and OsseoFix+ systems, by the surgeon community, failure to obtain FDA clearance or approval for new products, or unexpected or prolonged delays in the process, Alphatec Spine's ability to develop and expand its business in the United States, Asia and Europe, continuation of favorable third party payor reimbursement for procedures performed using Alphatec Spine's products, unanticipated expenses or liabilities or other adverse events affecting cash flow or Alphatec Spine's ability to successfully control its costs or achieve profitability, uncertainty of additional funding, Alphatec Spine's ability to compete with other competing products and with emerging new technologies, product liability exposure, patent infringement claims and claims related to Alphatec Spine's intellectual property. Please refer to the risks detailed from time to time in Alphatec Spine's SEC reports, including quarterly reports on Form 10-Q, reports on Form 8-K and annual reports on Form 10-K. Alphatec Spine disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.
Source: Alphatec Holdings
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.